Sotera Health

Executive Summary

Sotera Health is a leading global provider of mission-critical sterilization, lab testing, and advisory services for the healthcare industry. Operating through Sterigenics (sterilization), Nordion (Cobalt-60 supply), and Nelson Labs (testing), the company plays an indispensable role in ensuring the safety and efficacy of medical devices and pharmaceuticals. With an estimated valuation of $4.25 billion and strong market positioning, Sotera Health benefits from secular tailwinds including increasing regulatory requirements for sterilization and quality control, growing complexity of medical devices, and the essential nature of its services. Despite being private, the company’s performance closely tracks healthcare sterilization demand, which remains resilient.

Upcoming Catalysts (preview)

• 2027Resolution of Ethylene Oxide (EtO) Regulatory Uncertainty60% success
• Q4 2026Capacity Expansion for Sterilization Facilities80% success
• Q2 2027Potential IPO or Strategic Sale30% success